DNOW (NYSE:DNOW) Q4 2025 Earnings call February 20, 2026 09:00 AM ET Speaker6Good morning. My name is Jeannie, and I will be your conference operator today. At this time, I would like to welcome everyone to the DNOW fourth quarter and full year 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number ...

Herc Rentals FY Conference Summary Company Overview - **Company**: Herc Rentals (NYSE:HRI) - **Industry**: Equipment Rental - **Market Position**: Leading full-line equipment supplier in North America with a market size approaching $90 billion [4][5] - **Workforce**: Approximately 9,600 employees across over 600 locations in 46 states and five Western Canadian provinces [4] Core Insights - **Growth Strategy**: Herc Rentals has been generating above-market growth through investments in fleet, new greenfields, and mergers & acquisitions (M&A) [5] - **Recent Acquisition**: Closed the largest transaction in the industry by acquiring H&E Equipment Services, enhancing branch network and customer reach [6][7] - **Integration Success**: IT integration completed in 90 days, with branch and fleet optimization exercises underway to prepare for peak season [8][13] Financial Performance - **Cost Synergies**: Expected to achieve $125 million in cost synergies impacting EBITDA for 2026, with $35 million already realized in 2025 [21] - **Revenue Synergies**: Projected gross revenue synergies of $390 million over three years, with $40 million achieved in the latter half of 2025 and an expected $100-$120 million in 2026 [21][24] - **CapEx Guidance**: Projected gross CapEx of approximately $1 billion for 2026, with a focus on fleet optimization [31] Market Dynamics - **Rental Market Conditions**: Supply is readily available, with a disciplined market and no significant oversupply. Demand remains stable but challenging, particularly in regions without mega projects [35][36] - **Mega Projects**: $1 trillion worth of work in the pipeline, with Herc Rentals increasing its share in mega projects since 2023 [40][41] Competitive Landscape - **Market Discipline**: The competitive environment remains stable, with major players maintaining discipline in fleet management and market entry [56] - **Future Outlook**: Anticipated improvements in utilization rates and potential for rate increases in the latter half of 2026 [50] Strategic Focus - **Diversification Strategy**: Focus on top 100 metropolitan statistical areas (MSAs) to ensure resilience during uncertain times [6] - **Technology Leadership**: Continued investment in technology to enhance operational efficiency and customer interaction [5] Additional Considerations - **Debt Management**: Plans to utilize free cash flow, projected at $400 million-$600 million for 2026, to pay down debt and return to a 2-3 times leverage ratio by the end of 2027 [67] - **Market Sentiment**: Audience sentiment during the conference indicated a preference for debt paydown and a balanced view on stock valuation multiples for 2026 earnings [60][68]

Financial Data and Key Metrics Changes - For Q4 2025, equipment rental revenue increased by approximately 24% year-over-year, driven by the H&E acquisition and strong contributions from mega projects and specialty solutions [13] - Adjusted EBITDA rose by 19% compared to Q4 2024, benefiting from higher equipment rental revenue and a 53% increase in used equipment sales [13] - REBITDA, excluding used equipment sales, increased by 17% in Q4, with a REBITDA margin of 45% impacted by the lower margin acquired business [15] Business Line Data and Key Metrics Changes - The integration of specialty solutions capabilities across the combined network is a core priority, with plans to increase standalone or co-located specialty branches by approximately 25% [6] - By year-end, the fleet was realigned with the right equipment in the right locations, enhancing product portfolio and flexibility [7] - The sales force assimilation is showing good progress, with improvements in proficiency across the go-to-market strategy and early cross-selling success [8] Market Data and Key Metrics Changes - Local accounts represented 51% of rental revenue in 2025, compared to 49% for national accounts, with a long-term target of 60% local and 40% national revenue split [27] - The company expects 2026 to be relatively neutral to 2025 in local market demand, with government, infrastructure, MRO, and institutional construction demand offsetting moderate commercial sector activity [26] Company Strategy and Development Direction - The company aims to complete the integration of the acquired assets by the end of Q1 2026, focusing on branch network optimization and scaling the sales force [23] - Capital discipline remains a management imperative, with responsible investments prioritized to strengthen the business foundation while integrating the acquisition [12] - The company is targeting approximately $100-$120 million in incremental revenue synergies for 2026, driven by a broader fleet and new specialty locations [56] Management's Comments on Operating Environment and Future Outlook - The management expressed confidence in the operational and financial benefits of the acquisition, with expectations for improved productivity and cost efficiencies [10] - The fundamentals of the combined company are stronger, with a focus on capturing synergies and optimizing the new foundation for consistent performance [26] - The company anticipates generating approximately $390 million of gross revenue synergies through 2028, with $100-$120 million expected in 2026 [20] Other Important Information - The company generated $521 million of Free Cash Flow for the year ended December 31, 2025, with a Pro Forma leverage ratio of 3.9 times [18] - The company plans to invest roughly $950 million in gross CapEx for 2026, with net CapEx expected to be approximately $650 million [19] Q&A Session Summary Question: Clarification on guidance and EBITDA generation - Management expects cost synergies to contribute about $125 million to REBITDA in 2026, with revenue synergies estimated at $100-$120 million [42] Question: Cadence of Dollar Utilization - Pro forma dollar utilization is expected to decline in Q1 year-over-year, with improvement anticipated as the company moves out of the shoulder period [51] Question: Revenue synergies visibility - Revenue synergies will come from a broader fleet and the opening of 50 new specialty locations, with pricing tools integrated into the sales team [56] Question: Mega project competitiveness - The company is winning a targeted 10%-15% share of mega project opportunities, with a stable competitive landscape [60] Question: Specialty business go-to-market strategy - The company has successfully connected existing general rental customers with specialty offerings, leading to increased rental volumes [75]

Fifth Third Bancorp Conference Call Summary Company Overview - **Company**: Fifth Third Bancorp (NasdaqGS: FITB) - **Event**: 2026 Conference on February 10, 2026 Key Points Acquisition of Comerica - The acquisition of Comerica is viewed as a significant milestone for Fifth Third, enhancing its competitive position and operational capabilities [4][5] - The merger is expected to create a more efficient and growth-oriented franchise, with no tangible book dilution at close and anticipated tangible book value per share accretion each quarter [5] - Expected annual pre-tax expense synergies of $850 million, representing approximately 35% of Comerica's expense base, will be achieved through consolidating functions and optimizing operations [9][10] - The integration strategy emphasizes retaining key Comerica leaders to ensure continuity and stability [7] Integration Strategy - Integration activities are progressing ahead of schedule, with substantial advancements in data mapping and technology alignment [6] - The integration approach is centered on a "customer first" principle, focusing on enhancing client relationships and trust [9] - The company plans to accelerate customer conversion to Labor Day 2026, providing a clearer view of financial performance in Q4 2026 [6] Growth Potential - Fifth Third anticipates over $500 million in identifiable revenue synergies over the next five years, leveraging proven capabilities [10][11] - Plans to open 150 new financial centers in Texas from 2027 to 2029, aiming to achieve a top four branch share in major Texas cities [12][13] - The merger is expected to unlock significant opportunities in the middle market space, particularly in Texas and California, where Comerica has expertise [33] Organic Growth and Market Position - Fifth Third has experienced strong organic growth in the Southeast, with recent branch openings exceeding deposit goals by over 200% [21][22] - The company is focused on enhancing customer relationships through a proactive engagement strategy post-account opening [27][28] - The competitive landscape in the Southeast remains challenging, but Fifth Third's approach has proven effective in creating sticky client relationships [26] Financial Performance and Outlook - The company reported a 20% year-over-year increase in middle market loan production, indicating a positive outlook for organic growth [39] - Deposit balances have shown signs of recovery, particularly among lower FICO banded deposit customers [40] - The current deposit pricing environment remains competitive but rational, with no significant deterioration expected [43] Regulatory Environment - The company is monitoring regulatory changes, particularly regarding the Basel end game, which could impact capital evaluation [59][60] - Fifth Third maintains a robust capital position and continues to adapt its risk management frameworks in anticipation of regulatory developments [62] Conclusion - The Comerica acquisition is positioned to strengthen Fifth Third's franchise, enhance its market presence, and provide a long runway for sustainable growth [15][16] - The integration strategy is designed to ensure successful execution while maintaining focus on organic growth opportunities across key markets [16][20]

同时，美银表示看到收入协同效应的空间，特别是在财富管理、批发及交易银行业务的手续费收入方 面。恒生目前的收入结构更偏向净利息收入; 基于其强大的客户关系，美银认为存在显著的交叉销售机 会，而随着本地业务增长下，其重要性将进一步提升。 汇丰近日完成私有化恒生银行，估算税前总协同效应约为8至9亿美元，当中包括成本及收入协同效益。 美银预期恒生的成本基础中有20%具有协同效益，因恒生的成本本来已很高效，并会继续以独立品牌营 运且保留其自身的分行网络。 美银证券发布研报称，汇丰控股(00005)是其今年的首选标的之一，因为预期香港存款业务及亚洲财富 管理业务将有显著增长，而汇控在有关领域中已具备实质竞争优势，且管理层承诺将加大投资的领域; 现予目标价149.6港元及"买入"评级。 ...

Core Insights - The article discusses the strategic execution, value creation, and future planning of Waters Corporation, highlighting its transformation over the past five years and its focus on high-growth adjacent areas such as bioreagents and professional diagnostics [3][19]. Financial Performance Analysis - Adjusted operating profit margin over the past 12 months is industry-leading, exceeding the next competitor by approximately 180-80 basis points [4]. - Revenue growth for the past 12 months is around 8%, significantly higher than the industry average of 5%, with a weighted average growth rate three times that of other companies [4]. - Earnings per share (EPS) achieved double-digit growth, driven by factors such as GLP1 testing (contributing approximately $30 million in 2025), PFAS testing ($20 million), and Indian genetic testing ($30 million), collectively contributing over 250 basis points to growth [4]. Key Growth Drivers - Revenue growth is driven by instrument replacement (incremental sales exceeding $40 million within two years), increased service attach rates (from 43% in 2019 to 54% currently, a 2.2% annual increase), expansion of e-commerce channels (sales of chromatography columns through e-commerce increased from 20% to 45%, a 5% annual growth), growth in contract organization business (from 15% to 25%), and R&D investment (10% of product sales allocated to R&D) [5]. - Cost control achieved through optimization of manufacturing and supply chain, enhancing commercial and service efficiency [5]. Business Operations Overview - Core markets (pharmaceutical QA/QC, food environmental safety, etc.) have a scale of approximately $110 billion, with single-digit annual growth, slightly above industry growth [7]. - Adjacent areas (bioreagents, professional diagnostics, battery testing) have a scale of about $70 billion, with annual growth rates ranging from high single digits to low double digits, particularly with bioprocessing business growing at 50% [7]. - The Indian market shows a high teens growth rate, contributing approximately $30 million in revenue [8]. R&D Investment and Outcomes - R&D investment is about 10% of product sales [9]. - Innovative products include the Alliance liquid chromatography system (reducing errors by 40%, with a year-on-year growth of 270%), Xevo TQ Absolute mass spectrometer (PFAS testing, 40% annual growth), Max Peak Premier chromatography column (biologically inert, 35% annual growth), and charge detection mass spectrometer [9]. Future Outlook and Planning - Short-term goals for 2026 include a revenue growth framework with a mid-cycle instrument replacement period (6-year cycle), low single-digit compound annual growth rate, and special growth drivers contributing approximately 200 basis points [11]. - Long-term strategy focuses on high-growth end markets (bioreagents, diagnostics, battery testing) with a total addressable market (TAM) of approximately $1900-$2000 billion, and a projected revenue compound annual growth rate of 7% over the next five years [12]. Q&A Highlights - The 2026 growth expectation is influenced by the mid-cycle instrument replacement and special growth drivers, with new products further driving growth [14]. - The impact of manufacturing reshoring on TAM and revenue is anticipated to begin affecting product mix by the end of 2026, with expected high single-digit growth for instruments [15]. - The chemical business is driven by price, volume growth, and new products, with long-term growth reliant on innovation [16]. - Cost and revenue synergies from the BD business are expected to start in 2026, with specific quantification pending post-transaction completion [17]. Summary Remarks - Waters Corporation is executing its strategy from a position of strength, accelerating entry into high-growth adjacent areas through the acquisition of BD's life sciences and diagnostics business [19]. - The company aims to focus on building QC systems for bioreagents, optimizing microbiology business, and achieving cost and revenue synergies [19]. - Long-term goals include achieving industry-leading financial prospects, with a 7% revenue compound growth, margin expansion, and double-digit EPS growth [19].

Core Viewpoint - The company acknowledges that the acquisition of Supermeis New Materials Co., Ltd. has significantly impacted its operating profit, but it emphasizes the revenue synergy generated from the acquisition and its commitment to enhancing competitiveness in the high-end materials market [1] Group 1 - The company has experienced a notable increase in revenue scale since acquiring Supermeis, indicating positive revenue synergy effects [1] - The management plans to continue integration efforts to achieve brand and technology synergy, which is expected to strengthen its competitive position in the high-performance fiber and strategic emerging industries [1] - The company remains focused on maintaining strategic determination to build long-term industrial value despite the current performance challenges [1]

Summary of CorMedix Inc. Conference Call Company Overview - CorMedix Inc. is transitioning from a small-cap single-product company focused on DefenCath, an antimicrobial catheter lock solution, to a multi-product diversified specialty injectable hospital acute care platform following the acquisition of Millennium Therapeutics [3][4] Acquisition of Millennium Therapeutics - The acquisition is seen as transformational, providing CorMedix with seven commercial products, primarily anti-infectives and antifungals, and a stable revenue base of approximately $130 million [5][4] - The acquisition aligns with CorMedix's criteria for business development, including synergy with existing products, near-term accretion, and growth potential [4][5] Synergies and Growth Opportunities - Post-acquisition synergies are expected in both operating costs and revenue, with potential overlaps in hospital systems and accounts [7][6] - DefenCath's expansion into new indications, such as TPN and chemotherapy, is anticipated to align well with Millennium's existing deployment [8][10] Market Potential for Rezeo - The total addressable market for Rezeo in prophylaxis of fungal infections is estimated to exceed $2 billion, with peak annual sales projected over $200 million [12][11] - The current approved indication for invasive fungal infections has a smaller market opportunity of about $250 million, with challenges in hospital utilization [9][10] Dialysis Market Insights - The dialysis market is highly concentrated, with major players like DaVita and Fresenius controlling 90-95% of the market [16][17] - CorMedix has successfully onboarded large dialysis operators, which is crucial for the adoption of DefenCath [18][19] Clinical Trials and Future Milestones - A real-world evidence study with US Renal Care is underway, with interim results expected later this year [20][21] - Clinical trials for new indications of DefenCath are progressing, with hopes for approval by the end of 2027 [21][22] Future Business Development - CorMedix aims to pursue future business development opportunities that are synergistic and accretive, focusing on renal, hospital acute care, and oncology spaces [24][25] - The acquisition of Millennium Therapeutics is viewed as a significant step in mitigating risks associated with pricing uncertainties for DefenCath [25][26] Conclusion - The acquisition of Millennium Therapeutics is a pivotal move for CorMedix, enabling a shift to a multi-product company with diverse growth opportunities, particularly in the hospital acute care sector and the expansion of DefenCath [25][26]

Summary of JBT and Marell Conference Call Industry and Company Overview - The conference call discusses the merger between JBT Corporation (JBT) and Marell (MREL), focusing on the food and beverage processing industry [3][6][35] - JBT aims to enhance its position in the global food supply chain by combining with Marell, which specializes in poultry, meat, seafood, and pet food processing technologies [8][12] Core Points and Arguments - **Transaction Details**: JBT plans to acquire all outstanding shares of Marell, with a voluntary takeover offer expected to launch soon. The transaction is anticipated to close by the end of 2024 [3][14][15] - **Strategic Rationale**: The merger is expected to create a leading global food and beverage solutions company, leveraging complementary technologies and services to enhance customer operations and drive shareholder value [6][11][12] - **Market Growth**: The combined company is projected to grow revenue from approximately $3.5 billion in 2023 to about $4 billion by 2025, with nearly half of this revenue coming from recurring streams such as spare parts and services [27][32] - **Cost Synergies**: Expected annual run rate cost savings of approximately $70 million in the first year, growing to over $125 million by year three, primarily from operational efficiencies and reduced redundancies [29][70] - **Revenue Synergies**: Anticipated revenue uplift of over $75 million by the end of the third year post-close, driven by integrated solutions and cross-selling opportunities [30] Additional Important Insights - **Cultural Integration**: Emphasis on aligning the cultures of both companies to ensure a successful integration process, recognizing the importance of Marell's heritage [16][34] - **Customer Focus**: The combined entity aims to enhance customer relationships through improved service capabilities and integrated technology solutions, addressing operational efficiency and automation needs [22][74] - **Sustainability and Innovation**: Both companies are committed to sustainability, aiming to reduce food and packaging waste while improving resource efficiency [26][35] - **Regulatory Review**: The regulatory process is expected to be straightforward due to minimal overlaps in business operations, with confidence in receiving necessary approvals [41][42] Financial Metrics - JBT's revenue for the last four quarters ending March 31 was approximately $1.7 billion with an adjusted EBITDA margin of 16.6% [17] - Marell's revenue for the same period was about $1.8 billion with an adjusted EBITDA margin of 12.4% [18] - The combined company aims for an adjusted EBITDA margin of about 16% by 2025, factoring in synergies and market recovery [27][44] Conclusion - The merger between JBT and Marell is positioned as a strategic move to create a robust player in the food and beverage processing industry, with significant growth potential, operational efficiencies, and a strong commitment to customer service and sustainability [35][80]